Regimen-related Mortality Risk in Patients Undergoing Peritoneal Dialysis Using Hypertonic Glucose Solution: A...

Area of Science:

• Nephrology
• Internal Medicine
• Clinical Research

Background:

• Peritoneal dialysis (PD) is a common renal replacement therapy.
• The type and concentration of PD solutions can influence patient outcomes.
• Hypertonic glucose solutions are frequently used in PD but their long-term effects on mortality are debated.

Purpose of the Study:

• To quantify the association between different hypertonic peritoneal dialysis (PD) solution regimens and mortality risk.
• To identify specific PD regimens that may increase the risk of death.
• To analyze risk factors contributing to mortality in PD patients.

Main Methods:

• Retrospective cohort study of 300 home-based PD patients.
• Analysis of prescribed glucose-based PD solution regimens (original, shuffle, serialized).
• Multivariate survival analysis (Weibull model) adjusting for confounders.

Main Results:

• 38% of patients died during a median follow-up of 30 months.
• Continuous use of higher-strength PD solutions (serialized PD) was associated with a significantly lower survival rate (adjusted hazard ratio, 2.6).
• Age, duration on PD, hemoglobin, albumin, and oliguria were significant predictors of mortality.

Conclusions:

• Frequent exposure to high-concentration glucose PD solutions significantly increases mortality risk.
• Continuous prescription of hypertonic glucose PD solutions is particularly associated with a 2-fold higher death rate.
• Risk stratification and careful selection of PD regimens are crucial for improving patient survival.